SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-029191
Filing Date
2024-03-11
Accepted
2024-03-11 16:00:31
Documents
100
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ctmx-20231231.htm   iXBRL 10-K 3179129
2 EX-19.1 ctmx-ex19_1.htm EX-19.1 150739
3 EX-23.1 ctmx-ex23_1.htm EX-23.1 6632
4 EX-31.1 ctmx-ex31_1.htm EX-31.1 13498
5 EX-31.2 ctmx-ex31_2.htm EX-31.2 13335
6 EX-32.1 ctmx-ex32_1.htm EX-32.1 11087
7 EX-97.1 ctmx-ex97_1.htm EX-97.1 82986
8 GRAPHIC img36236167_0.jpg GRAPHIC 8463
9 GRAPHIC img216791825_0.jpg GRAPHIC 8463
10 GRAPHIC img240975503_0.jpg GRAPHIC 115948
11 GRAPHIC img240975503_1.jpg GRAPHIC 110409
12 GRAPHIC img240975503_2.jpg GRAPHIC 25155
13 GRAPHIC img240975503_3.jpg GRAPHIC 138758
  Complete submission text file 0000950170-24-029191.txt   13046457

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ctmx-20231231.xsd EX-101.SCH 1772412
102 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-20231231_htm.xml XML 1874614
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37587 | Film No.: 24737906
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)